China SXT Pharmaceuticals - SXTC Company profit before taxes, interest and amortization
China SXT Pharmaceuticals (SXTC) relies on trust in legacy formulas and the expertise of dedicated technologists. The operating profit dynamics captured by the GURU.Markets platform demonstrate sales efficiency, and 0.00 shows the value of this parameter. Despite personnel changes in marketing, China SXT Pharmaceuticals (SXTC) maintains its position through strict quality control of raw materials for state pharmacies.
China SXT Pharmaceuticals (SXTC) - metric breakdowns and financial figures
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio China SXT Pharmaceuticals|SXTC - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio SXT China|SXTC - Company Aggregate Debts|Debt to Net Assets Ratio China SXT Pharmaceuticals, Inc.|SXTC - Company Long-Term Debts|Short-Term Debt Volume China SXT Pharmaceuticals|Immediate Liquidity Ratio sxtchina.com
- earnings and market ratios statistics:
SXTC - Net Profit|Projected Future Earnings China SXT Pharmaceuticals|SXTC - Price to Earnings Ratio|Future Price to Earnings Multiple China SXT Pharmaceuticals|SXTC - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio SXT China|SXTC - Operating profit before deduction of amortization|Earnings per share for the last 12 months China SXT Pharmaceuticals|SXTC - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months sxtchina.com|SXTC - Net earnings per share growth this year|Expected earnings per share trend next year China SXT Pharmaceuticals
- sales revenue and business income indicators:
Summary company analytics:sxtchina.com
This indicator measures the difference between operating income and expenses, reflecting the actual cash efficiency of the business excluding debt load and depreciation. For China SXT Pharmaceuticals (SXTC), this metric confirms the resilience of the full-cycle herbal processing and stable demand for natural pharmaceuticals, which clearly demonstrates the recorded EBITDA level as a marker of the issuer's operational strength.
Who China SXT Pharmaceuticals competes with
Company profit before taxes, interest and amortization HLN (Haleon plc)|KVUE: Operating profit before deduction of amortization|Verona Pharma - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharma - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization perrigo.com PRGO|Profit before payment of interest, taxes and amortization Alvotech SA (ALVO)|LQDA (Liquidia Corp) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA GLPG (Galapagos N.V.)|Operating profit EBITDA ANI Pharmaceuticals Corp ANIP|Afrezza - Operating profit EBITDA|amphastar.com (AMPH) - Operating profit before deduction of amortization|PCRX: Operating profit EBITDA|SPRY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Theravance|Profit before interest, taxes and amortization Aquestive Corp AQST|Operating profit EBITDA SCPH|TECX - Profit before interest, taxes and amortization|Tonix Pharmaceuticals Holding Corp. - Operating profit before deduction of amortization|EPRX: Operating profit before amortization|BHST: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Invizyne|Oramed Pharmaceuticals Inc. (ORMP) - Profit before payment of interest, taxes and amortization|ENTX (Entera Bio Ltd) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization HYFT|ABVC BioPharma, Inc. - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA CPIX|Operating income before deduction of amortization Quantum BioPharma Corp|Profit before payment of interest, taxes and amortization FibroGen FGEN|Operating profit EBITDA telomirpharma.com TELO|Rani Therapeutics Inc - Operating profit EBITDA|Income before deduction of interest, taxes and amortization SNYR (synergychc.com)|Rallybio (RLYB) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Lexaria Bioscience Corp|Operating profit before deduction of amortization PULM|PTHL - Operating profit before depreciation charges|Operating profit EBITDA APM|Operating income before deduction of amortization Lyra Therapeutics|Profit before payment of interest, taxes and amortization Impact BioMedical Inc IBO|TNFA - Operating profit before deduction of amortization|cbdMD, Inc. - Operating profit EBITDA|Income before deduction of interest, taxes and amortization PRFX (PainReform Ltd.)|CYTO (altamiratherapeutics.com) - Operating profit before deduction of amortization|LIPO: Company profit before taxes, interest and amortization|OPTN (Optinose) - Operating profit EBITDA|Operating profit before deduction of amortization Pieris (PIRS)|Profit before payment of interest, taxes and amortization Procaps Group S.A. (PROC)|Operating profit EBITDA petrospharma.com (PTPI)|Profit before payment of interest, taxes and amortization Qilian International Holding QLI|Income before deduction of interest, taxes and amortization SLRN|TFF Pharmaceuticals, Inc. - Operating profit EBITDA
